InMed Pharmaceuticals Inc. (OTC: IMLFF) (CSE: IN)Detailed Quote · Free Stock Analysis
InMed Pharmaceuticals Inc. is a pre-clinical stage biopharmaceutical company specializing in the research, development and commercialization of cannabinoid-based therapies to treat human diseases with high unmet medical needs.
The company has three core assets: a proprietary Bioinformatics assessment tool to match individual (or combination of) cannabinoids against disease targets, a proprietary Biosynthesis cannabinoid manufacturing system to economically produce all 90+ cannabinoids at pharmaceutical-grade (>99.5% purity), and a drug development program.
- InMed Pharmaceuticals’ Biosynthesis Platform Results in an Industry First
- InMed Announces Positive Pre-Clinical Data on an Ocular Hydrogel Formulation using a Biosynthesized Cannabinoid
- InMed Pharmaceuticals Files Provisional Patent for Pain Program
- InMed Continues to Make Significant Strides on Biosynthesis Program Development
- InMed Pharma: A Leader in Cannabinoid Biosynthesis
Around the Web
- NetworkNewsWire Announces Publication Outlining Innovations Driving Value in Cannabis Industry
- InMed to Present at Cannabis-Based Science & Medicine Conference
- NetworkNewsWire Announces Publication Featuring Innovative Approach to Cannabis R&D
- NetworkNewsWire Announces Publication that Highlights Big Pharma’s Increasing Interest in Cannabis Biotech Companies
- NetworkNewsWire Announces Publication Highlighting Big Pharma’s Appetite for M&A Possibilities in Cannabis
Follow Us on Social Media
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.